Alphatec Holdings, Inc. reported strong second-quarter results, with total revenue growing by 35% to $84 million, including a 30% increase in organic revenue. The company's performance was driven by increased surgeon users and strong adoption of its products, leading to growth in revenue per surgery. ATEC also increased its full-year revenue guidance to $325 million, reflecting 34% growth.
Total revenue increased by 35% to $84 million, with organic revenue growth of 30%.
EOS imaging generated $12 million in revenue, reflecting 49% growth on a pro-forma basis.
Surgeon users increased by 23% compared to the prior year, contributing to revenue growth.
The company increased full-year revenue guidance to $325 million, representing 34% growth.
The Company now expects total revenue of $325 million for the fiscal year ended December 31, 2022, reflecting growth of approximately 34% compared to the full year 2021. This includes organic revenue growth of approximately 31% and $48 million of revenue related to EOS imaging.
Analyze how earnings announcements historically affect stock price performance